Neurostimulation devices are battery-powered devices that are designed to send an electrical stimulation to the brain, central, and peripheral nervous system. External usage of neurostimulation devices is gaining momentum in the North American markets, due to the convenience, high comfort, and versatility offered by these devices. External neuromodulation is an advanced technique generally used to treat nerve-related disorders. At present, external neurostimulation and neuromodulation are widely used to treat disorders such as migraines, tennis elbow, spasms, arthritis, and so on. The growing demand from the aging population in the region is expected to drive the external neurostimulation/neuromodulation devices market in North America.
The North American external neurostimulation/neuromodulation devices market is among the major contributors to the global neurostimulation/neuromodulation devices market, having accounted for a market share of 32.1% in 2013. The North American market is projected to grow at a CAGR of 9.7% from 2013 to 2018. The U.S. holds a majority of the North American market, followed by Canada and Mexico.
The North American region is highly advanced in terms of medical technologies, mainly owing to heavy investments in research & development for the life sciences, pharmaceuticals, and biotechnology sectors. The aging population in North America, which currently stands at over 40% of the population, is the largest consumer of the external neurostimulation and neuromodulation devices market. Due to aging, obesity, and unhealthy lifestyles, the prevalence of disorders such as arthritis, osteoporosis, spasm, and migraines is high in the North American region, especially in the U.S. and Canada. The high demand for neurostimulation & neuromodulation devices is also a result of the growing awareness among people regarding various technological advancements in the delivery of medical care and treatment of lifestyle & chronic disorders. The major companies expected to cater to the growing demands in the North American region include Medtronic, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.), among others.
The North America external neurostimulation/neuromodulation devices market report provides insights into the segmentation of the market. It has been segmented in terms of types, surgery procedures, and major countries in the region. The main surgery procedures in the market are direct nerve repair, nerve grafting, and stem cell therapy. On the basis of types, the market has been segmented into transcranial magnetic stimulation and transcutaneous electrical nerve stimulation. The most important macro indicator for this market is healthcare expenditure, which was recorded at $2.8 trillion in 2012.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Asian Neurostimulation/Neuromodulation devices Market
The Asian Neurostimulation/Neuromodulation market was expected to reach from $415.32 million in 2013 to $777.62 million by 2018 at a CAGR of 13.4%. The market divided by 2 segments such as Internal Neuromodulation and External Neuromodulation. The internal neuromodulation devices market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external neuromodulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Major players in the market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.).
European Neurostimulation/Neuromodulation Devices Market
The report also provides a detailed competitive landscaping of companies operating in this market. Segment- and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of major companies are detailed in the report. Boston Scientific (U.S.), Cyberonics (U.S), Medtronic, Inc. (U.S.), Depuy Synthes (Johnson & Johnson) (U.S.), and St. Jude Medical Inc. (U.S.) are some of the key players engaged in this market.
North America Internal Neuromodulation Devices Market
The North America neuromodulation market has been segmented by procedure, modality, and geography. On the basis of procedure, the market is further segmented into internal and external stimulation. The internal stimulation segment accounted for a share of 87.4% in the neuromodulation market. The market based on modality covers internal and external modality. The internal modality segment accounted for a share of 85.9% in the neuromodulation market.